Vitaly Ustimenko to Present at Hospital Build & Infrastructure Russia Congress & Exhibition
Vitaly Ustimenko, Chief Financial Officer of MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), Russia’s leading provider of private women’s and children’s healthcare, will present at the upcoming Hospital Build & Infrastructure Russia Exhibition & Congress taking place in Moscow on 13-15 October 2014.
During his presentation on 14 October 2014, Vitaly will share insight into MDMG’s experience in raising funding for the implementation of its medical projects. In particular, his presentation will include an overview of organic growth and M&A projects carried out by the Company, as well as sources of their financing. Vitaly will present MDMG’s London Initial Public Offering in October 2012 as one of the Company’s successful examples of financing sources. In addition, Vitaly will express his views on the significant growth potential of Russia’s private healthcare sector, and on the current status of the domestic industry as compared to other countries.
The Hospital Build & Infrastructure Russia Exhibition & Congress is a major platform dedicated to showcasing and promoting current and future Russian healthcare projects. The event is attended by leading top managers, investors, and commissioners and ministry officials working in the healthcare sector.
No new material information will be disclosed at the event.
For further information please contact:
| Investors | Media |
| Elena RomanovaMD Medical Group Investments Plc Tel: +7 495 331 4120 e.romanova@mcclinics.ru |
EM Moscow Tom Blackwell / Sergii Pershyn Tel: +7 495 363 2849 MDMG@em-comms.com |
| Consilium Strategic Communications London Emma Thompson / Matthew Neal Tel: +44 20 7309 5700 MDMG@em-comms.com |
About MD Medical Group
MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 17 modern healthcare facilities, including 2 hospitals in Moscow (Perinatal Medical Center (PMC) and Lapino hospital) and 15 outpatient clinics in Moscow, St. Petersburg, Ufa, Perm, Samara and Samara region, Irkutsk and Yaroslavl. In addition, the company operates 3 franchised outpatient clinics operate in Kyiv, Ukraine, and its third hospital, in Ufa, is scheduled to open on 31 October 2014. A new outpatient clinic, in Ryazan, is expected to open in Q1 2015.
In 1H 2014, there were 2,118 deliveries in PMC and Lapino. The number of outpatient treatments for 1H 2014 in the Company's clinics totalled 385,908.
The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
Forward-Looking Statements:
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.